
Jk Agri Genetics (JKAGRI) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
919.3M
Gross Profit
366.7M
39.89%
Operating Income
166.2M
18.08%
Net Income
122.8M
13.36%
EPS (Diluted)
₹26.49
Balance Sheet Metrics
Total Assets
3.0B
Total Liabilities
1.9B
Shareholders Equity
1.1B
Debt to Equity
1.77
Cash Flow Metrics
Revenue & Profitability Trend
Jk Agri Genetics Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.6B | 1.5B | 2.0B | 2.5B | 2.2B |
Cost of Goods Sold | 1.0B | 1.0B | 1.2B | 1.3B | 1.2B |
Gross Profit | 608.6M | 475.5M | 778.7M | 1.1B | 1.0B |
Gross Margin % | 37.6% | 32.1% | 38.8% | 45.7% | 44.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 134.4M | 233.4M | 256.9M | 195.2M |
Other Operating Expenses | 375.3M | 289.2M | 260.8M | 305.9M | 238.2M |
Total Operating Expenses | 375.3M | 423.6M | 494.2M | 562.9M | 433.4M |
Operating Income | -141.6M | -286.6M | -107.7M | 133.5M | 180.8M |
Operating Margin % | -8.7% | -19.4% | -5.4% | 5.4% | 8.1% |
Non-Operating Items | |||||
Interest Income | - | 2.6M | 3.0M | 23.1M | 7.3M |
Interest Expense | 58.9M | 79.5M | 68.9M | 53.7M | 61.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -24.7M | -296.1M | -152.8M | 102.6M | 100.2M |
Income Tax | 394.0K | -87.9M | -44.8M | 25.2M | 28.5M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 24.6% | 28.4% |
Net Income | -25.1M | -208.2M | -108.0M | 77.3M | 71.7M |
Net Margin % | -1.6% | -14.1% | -5.4% | 3.1% | 3.2% |
Key Metrics | |||||
EBITDA | -50.3M | -216.6M | -81.5M | 204.2M | 230.0M |
EPS (Basic) | ₹-5.41 | ₹-44.90 | ₹-23.29 | ₹16.67 | ₹16.70 |
EPS (Diluted) | ₹-5.41 | ₹-44.90 | ₹-23.29 | ₹16.67 | ₹16.70 |
Basic Shares Outstanding | 4637338 | 4636963 | 4636963 | 4636963 | 4292868 |
Diluted Shares Outstanding | 4637338 | 4636963 | 4636963 | 4636963 | 4292868 |
Income Statement Trend
Jk Agri Genetics Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 38.8M | 9.8M | 16.9M | 108.6M | 152.5M |
Short-term Investments | 1.1B | 613.5M | 548.9M | 390.8M | 345.2M |
Accounts Receivable | 423.4M | 521.8M | 698.7M | 1.0B | 768.6M |
Inventory | 722.7M | 1.1B | 1.4B | 1.4B | 1.2B |
Other Current Assets | 22.5M | 13.3M | 14.1M | -40.0K | 18.0M |
Total Current Assets | 2.3B | 2.3B | 2.7B | 3.0B | 2.6B |
Non-Current Assets | |||||
Property, Plant & Equipment | - | 120.3M | 56.5M | 56.5M | 56.5M |
Goodwill | 279.0M | 252.3M | 186.7M | 81.7M | 86.2M |
Intangible Assets | 279.0M | 252.3M | 186.7M | 81.7M | 86.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 236.0K | - | 153.0K | 477.0K | 7.6M |
Total Non-Current Assets | 661.4M | 776.9M | 596.9M | 467.7M | 506.0M |
Total Assets | 3.0B | 3.1B | 3.3B | 3.4B | 3.1B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 930.8M | 784.9M | 948.8M | 1.1B | 898.0M |
Short-term Debt | 29.9M | 223.6M | 291.8M | 180.5M | 184.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 886.1M | 99.5M | 102.9M | 83.0M | 68.9M |
Total Current Liabilities | 1.9B | 1.8B | 1.9B | 1.9B | 1.6B |
Non-Current Liabilities | |||||
Long-term Debt | 2.1M | 98.0M | 111.8M | 137.5M | 80.8M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 1.3M | 1.3M | 1.5M | 1.5M | 736.0K |
Total Non-Current Liabilities | 13.9M | 113.3M | 130.9M | 160.9M | 101.2M |
Total Liabilities | 1.9B | 2.0B | 2.0B | 2.0B | 1.7B |
Equity | |||||
Common Stock | 46.4M | 46.4M | 46.4M | 46.4M | 46.4M |
Retained Earnings | - | 166.4M | 374.6M | 489.6M | 419.2M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.1B | 1.1B | 1.3B | 1.4B | 1.4B |
Key Metrics | |||||
Total Debt | 32.0M | 321.6M | 403.6M | 318.0M | 264.8M |
Working Capital | 427.3M | 436.6M | 840.4M | 1.1B | 948.8M |
Balance Sheet Composition
Jk Agri Genetics Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -24.7M | -296.1M | -152.8M | 102.6M | 100.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -98.5M | 479.3M | 326.8M | -403.2M | -385.6M |
Operating Cash Flow | -193.5M | 258.5M | 220.8M | -268.9M | -202.2M |
Investing Activities | |||||
Capital Expenditures | 690.1M | -129.8M | -109.4M | -7.9M | -8.9M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | 690.1M | -129.8M | -109.4M | -7.9M | -8.9M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | -7.0M | -7.0M | - |
Debt Issuance | - | 0 | 0 | 115.0M | 0 |
Debt Repayment | -111.8M | -25.7M | -46.4M | -47.6M | -40.2M |
Financing Cash Flow | -255.9M | -127.7M | 90.7M | 62.5M | 38.9M |
Free Cash Flow | 34.2M | 232.7M | 12.5M | -17.2M | 201.7M |
Net Change in Cash | 240.7M | 937.0K | 202.0M | -214.3M | -172.2M |
Cash Flow Trend
Jk Agri Genetics Key Financial Ratios
Valuation Ratios
Price to Book
1.97
Price to Sales
1.21
Profitability Ratios
Profit Margin
0.68%
Operating Margin
18.08%
Return on Equity
-2.33%
Return on Assets
-0.84%
Financial Health
Current Ratio
1.23
Debt to Equity
2.98
Beta
-0.04
Per Share Data
EPS (TTM)
₹-5.40
Book Value per Share
₹232.05
Revenue per Share
₹376.84
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
jkagri | 2.1B | - | 1.97 | -2.33% | 0.68% | 2.98 |
Coromandel | 726.9B | 31.51 | 6.40 | 18.41% | 8.56% | 6.95 |
PI Industries | 623.4B | 37.62 | 6.14 | 17.58% | 20.81% | 1.81 |
Kothari Industrial | 48.1B | -259.77 | 23.29 | -17.17% | -18.66% | 2.23 |
National Fertilizers | 47.5B | 25.61 | 1.75 | 6.98% | 0.93% | 73.68 |
Bharat Rasayan | 43.9B | 31.11 | 3.88 | 13.31% | 12.01% | 7.54 |
Financial data is updated regularly. All figures are in the company's reporting currency.